Inhibition of destructive autoimmune arthritis in FcgammaRIIa transgenic mice by small chemical entities (Q39912703)

15 September 2017

title

Inhibition of destructive autoimmune arthritis in FcgammaRIIa transgenic mice by small chemical entities (English)

1 reference

15 September 2017

6

1 reference

15 September 2017

Geoffrey A Pietersz

1

1 reference

15 September 2017

Patricia L Mottram

2

1 reference

15 September 2017

Nicholas C van de Velde

3

1 reference

15 September 2017

Caroline Tan Sardjono

4

1 reference

15 September 2017

Sandra Esparon

5

1 reference

15 September 2017

Gerard Moloney

7

1 reference

15 September 2017

Jonathan B Baell

8

1 reference

15 September 2017

Tom D McCarthy

9

1 reference

15 September 2017

Barry R Matthews

10

1 reference

15 September 2017

Maree S Powell

11

1 reference

15 September 2017

P Mark Hogarth

12

1 reference

15 September 2017

publication date

25 November 2008

1 reference

Immunology & Cell Biology

15 September 2017

published in

1 reference

15 September 2017

volume

87

1 reference

15 September 2017

issue

1

1 reference

15 September 2017

page(s)

3-12

1 reference

FcgammaRII and multi-system autoimmune disease

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Fc receptors are major mediators of antibody based inflammation in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Characterization of FcR Ig-binding sites and epitope mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Mast cells in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Fc receptors of human Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Structure and function of human and murine receptors for IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Clinical relevance of Fc gamma receptor polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Animal models of arthritis: relevance to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Humanized mouse models of FcR clearance in immune platelet disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

The role of FcgammaRIIa as an inflammatory mediator in rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Biochemical analysis and crystallisation of Fc gamma RIIa, the low affinity receptor for IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

FcgammaRIIa is a target for modulation by TNFalpha in human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Expression of FcgammaRIII is required for development of collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Collagen-induced arthritis, an animal model of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

A role of FcgammaRIIB in the development of collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Role of activatory Fc gamma RI and Fc gamma RIII and inhibitory Fc gamma RII in inflammation and cartilage destruction during experimental antigen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Alteration of the Fc gamma RIIa dimer interface affects receptor signaling but not ligand binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Past, present and future drug treatment for rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Fifty years of experience with cortisone therapy in the study and treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

The Inhibitory Receptor FcγRII Reduces Joint Inflammation and Destruction in Experimental Immune Complex-Mediated Arthritides Not Only by Inhibition of FcγRI/III but Also by Efficient Clearance and Endocytosis of Immune Complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Inhibitory Fc gamma receptors: from gene to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Characterization of the FcgammaRIIA promoter and 5'UTR sequences in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

A novel human CD32 mAb blocks experimental immune haemolytic anaemia in FcgammaRIIA transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Soluble FcgammaRIIa inhibits rheumatoid factor binding to immune complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Granulocyte-macrophage colony stimulating factor exacerbates collagen induced arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

Inhibitory pathways triggered by ITIM-containing receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

7 January 2021

Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

7 January 2021

Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

7 January 2021

Molecular basis of Fc receptor function

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

7 January 2021

Development of anti-TNF therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

7 January 2021

A critical role for Fc gamma RIIB in the induction of rheumatoid factors

1 reference

https://api.crossref.org/works/10.1038%2FICB.2008.82

7 January 2021

Identifiers

DOI

10.1038/ICB.2008.82

1 reference

15 September 2017

1 reference